ImmunityBio (IBRX) Goodwill & Intangibles (2014 - 2026)

ImmunityBio (IBRX) has reported Goodwill & Intangibles for 12 consecutive years, with $12.9 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Goodwill & Intangibles fell 16.56% year-over-year to $12.9 million; the TTM figure through Mar 2026 stood at $12.9 million (down 16.56% YoY), while the FY2025 annual figure was $14.0 million, down 12.43% from the prior year.
• Goodwill & Intangibles declined to $12.9 million in Q1 2026 per IBRX's latest filing, from $14.0 million in the prior quarter.
• Across five years, Goodwill & Intangibles topped out at $22.3 million in Q1 2022 and bottomed at $12.9 million in Q1 2026.
• Historically, Goodwill & Intangibles has averaged $17.4 million across 5 years, with a median of $16.6 million in 2024.
• Annual changes were most pronounced in 2022 — Goodwill & Intangibles jumped 1454.17% — and 2026, when it decreased 16.56%.
• ImmunityBio's Goodwill & Intangibles stood at $20.0 million in 2022, then declined by 14.55% to $17.1 million in 2023, then decreased by 6.79% to $15.9 million in 2024, then decreased by 12.43% to $14.0 million in 2025, then dropped by 7.65% to $12.9 million in 2026.
• Business Quant data shows IBRX's Goodwill & Intangibles at $12.9 million in Q1 2026, $14.0 million in Q4 2025, and $14.5 million in Q3 2025.